Want to join the conversation?
$MDT is seeing strong acceptance for its new therapies across all groups. Including the benefit of extra week, emerging markets growth vector contributed approx. 190BP to 1Q16 total growth. Regionally, Middle East and Africa was weaker, but $MDT reported notable improvements China (low double digits), India (mid teens), and Russia (upper teens).
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)